Ads
related to: Prostate Proconsumereview.org has been visited by 100K+ users in the past month
Search results
MacroGenics reports progress in prostate cancer study By Investing.com
Investing.com· 2 days agoThe study investigates vobra duo, an antibody-drug conjugate (ADC), in patients with metastatic...
...Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across...
Digital Journal· 6 days ago“The TACT 5-year clinical trial data, along with multiple real-world reports on the safety, efficacy and durability of TULSA from U...
Earnings call: Veracyte sees robust growth driven by diagnostics platform By Investing.com
Investing.com· 4 days agoThe company's revenue reached $96.8 million, marking a 17% increase from the same period last year,...
Earnings call: FibroGen reports Q1 2024 results, optimistic about pipeline By Investing.com
Investing.com· 5 days agoThe company highlighted the upcoming top line data from Phase 3 studies for pamrevlumab in...
Johnson & Johnson Advances Its Two Bladder Cancer Studies, Releases Latest Data
Benzinga via Yahoo Finance· 6 days agoOn Sunday, Johnson & Johnson (NYSE:JNJ) ) released updated results from an open-label, multicenter,...
Earnings call: Oncternal reports Q1 results and clinical progress
Investing.com· 2 days agoOncternal Therapeutics Inc. (ONCT) provided a comprehensive update on its business and financial...
Celebrity News | Entertainment News | TMZ.com
TMZ· 2 days agoArticles - January, 2013 Hugh Hefner and Crystal Harris -- Married!! For Real This Time Ex-NFL Star Jason Taylor -- Stiff-Armed in $11k Lawsuit by Pro Garage Organizers Jon Heder -- Watch Me Sing Karaoke With a Hot Babe
Citi cuts ORIC Pharmaceuticals stock price target post 1Q24 pipeline update By Investing.com
Investing.com· 5 days agoORIC Pharmaceuticals is set to begin combination trials for its drug candidate, ORIC-944, a PRC2...
Dr. Roach: Brown semen usually doesn't present a health concern
St. Louis Post-Dispatch· 3 days agoDr. Roach: I am an 85-year-old male. Other than being a Type 2 diabetic, I am still active and in good health. I do have a concern; on the rare
FibroGen Shares Climb On Strong Q1 Sales - FibroGen (NASDAQ:FGEN)
Benzinga· 5 days agoFibroGen, Inc. FGEN shares are trading higher Tuesday after the company posted mixed first-quarter...